Allergan Inc. (NYSE:AGN) touted a strong quarter on the back on growing sales.
The Irvine, Calif.-based company saw strong growth in revenue in the three months ended June 30, posting $1.4 billion in sales, which amounts to a 14 percent increase over $1.2 billion in sales reporting during the same time last year.
Device sales jumped 12 percent to $245 million for the quarter, compared to $219 million in Q2 2010.